w88 casino News Network (provided by the Competition Law Center Office)2017Year9month13-15Days, duration3The 7th Asia-Pacific Medical Equipment Compliance Conference was held in Pudong, Shanghai today. Professor Huang Yong from the Law w88 casino of the w88 casino was invited to attend and deliver a speech. The Asia-Pacific Medical Equipment Compliance Conference is an important part of the International Pharmaceutical Compliance Conference. It is co-sponsored by the Asia-Pacific Medical Industry Compliance Organization, the International Medical Ethics and Compliance Professional Association and the Pharmaceutical Compliance Forum, and is held annually in the Asia-Pacific region. The members of the three organizing organizations include almost all pharmaceutical giants in the Asia-Pacific region. The conference invites representative corporate executives, experts, industry association representatives and lawyers to conduct cutting-edge discussions on compliance issues in the pharmaceutical industry, which has extensive influence in the pharmaceutical field.
Professor Huang Yong gave a speech
147661_7828FCPA(Foreign Anti-Corruption Act) and my country’s Anti-Unfair Competition Law have expressed their opinions on the issue of commercial bribery. As an act prohibited by various countries, commercial bribery has both differences in regulations in different jurisdictions and convergence with the integration of the world economy. The revision of China's Anti-Unfair Competition Law also reflects this convergence. On this basis, he introduced the relevant anti-monopoly and anti-unfair competition law enforcement in China's pharmaceutical industry, including the estazolam case, the allopurinol tablet case, and the case of abuse of market dominance by Southwest Pharmaceutical No. 2 Factory and other enterprises. At the same time, he also introduced the widely watched revision of China's Anti-Unfair Competition Law, which deepened the knowledge and understanding of this revision of the law among experts, scholars, executives and corporate legal affairs in the Asia-Pacific region. Finally, he integrated the above content and proposed a solution to the competition and compliance issues of pharmaceutical companies.
This conference is the highest-level meeting of the pharmaceutical industry in the Asia-Pacific region, attracting the participation of pharmaceutical giants from various regions in the Asia-Pacific region. Professor Huang Yong and a number of heavyweight guests appeared on the homepage of the conference's official website as the keynote speaker. His speech blended Chinese and Western methods, deepened the guests' knowledge and understanding of China's competition laws, and provided ideas for solving competition compliance issues for Chinese and foreign pharmaceutical companies.
